Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
06 2020
Historique:
received: 01 03 2019
revised: 23 07 2019
accepted: 27 07 2019
pubmed: 8 8 2019
medline: 3 7 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

The purpose of the study was to evaluate whether histogram analysis of apparent diffusion coefficient (ADC) can predict pathological complete response (pCR) and survival in patients with esophageal squamous cell carcinoma (ESCC) after chemoradiotherapy (CRT). We retrospectively identified 58 patients with ESCC who underwent surgery after CRT between 2007 and 2016. Associations of pretreatment histogram derived ADC parameters with pathological response and survival were analyzed. Tumors achieved pCR (10 patients, 17.2%) showed significant lower ADC, higher kurtosis, and higher skewness than those of non-pCR (p = 0.005, 0.007, <0.001, respectively). Receiver operating characteristics analysis demonstrated skewness was the best predictor for pCR (AUC = 0.86), with a cut off value of 0.50 (accuracy, 86.2%). In Kaplan-Meier analysis, patients with higher skewness tumors (≥0.50) showed a significantly better recurrence free survival (p = 0.032, log-rank). Histogram analysis of ADC can enable prediction of pCR and survival in ESCC patients treated with preoperative CRT. ADC histogram analysis can be an imaging biomarker for esophageal cancer patients treated with CRT.

Sections du résumé

BACKGROUND
The purpose of the study was to evaluate whether histogram analysis of apparent diffusion coefficient (ADC) can predict pathological complete response (pCR) and survival in patients with esophageal squamous cell carcinoma (ESCC) after chemoradiotherapy (CRT).
METHODS
We retrospectively identified 58 patients with ESCC who underwent surgery after CRT between 2007 and 2016. Associations of pretreatment histogram derived ADC parameters with pathological response and survival were analyzed.
RESULTS
Tumors achieved pCR (10 patients, 17.2%) showed significant lower ADC, higher kurtosis, and higher skewness than those of non-pCR (p = 0.005, 0.007, <0.001, respectively). Receiver operating characteristics analysis demonstrated skewness was the best predictor for pCR (AUC = 0.86), with a cut off value of 0.50 (accuracy, 86.2%). In Kaplan-Meier analysis, patients with higher skewness tumors (≥0.50) showed a significantly better recurrence free survival (p = 0.032, log-rank).
CONCLUSIONS
Histogram analysis of ADC can enable prediction of pCR and survival in ESCC patients treated with preoperative CRT.
A SHORT SUMMARY
ADC histogram analysis can be an imaging biomarker for esophageal cancer patients treated with CRT.

Identifiants

pubmed: 31387687
pii: S0002-9610(19)30265-X
doi: 10.1016/j.amjsurg.2019.07.040
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1024-1029

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Atsushi Hirata (A)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Koichi Hayano (K)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan. Electronic address: hayatin1973@yahoo.co.jp.

Gaku Ohira (G)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Shunsuke Imanishi (S)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Toshiharu Hanaoka (T)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Kentaro Murakami (K)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Tomoyoshi Aoyagi (T)

Department of Surgery, Funabashi Municipal Medical Center, Japan.

Kiyohiko Shuto (K)

Department of Surgery, Teikyo University Chiba Medical Center, Japan.

Hisahiro Matsubara (H)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH